100 related articles for article (PubMed ID: 1071971)
1. Subversive activity of syngeneic tumor cells as an escape mechanism from immune surveillance and the role of prostaglandins.
Plescia OJ; Grinwich K; Plescia AM
Ann N Y Acad Sci; 1976; 276():455-65. PubMed ID: 1071971
[TBL] [Abstract][Full Text] [Related]
2. Subversion of immune system by tumor cells and role of prostaglandins.
Plescia OJ; Smith AH; Grinwich K
Proc Natl Acad Sci U S A; 1975 May; 72(5):1848-51. PubMed ID: 1057174
[TBL] [Abstract][Full Text] [Related]
3. Tumor-mediated immunosuppression: prevention by inhibitors of prostaglandin synthesis.
Grinwich KD; Plescia OJ
Prostaglandins; 1977; 14(6):1175-82. PubMed ID: 601249
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice.
Pelus LM; Strausser HR
Int J Cancer; 1976 Nov; 18(5):653-60. PubMed ID: 186413
[TBL] [Abstract][Full Text] [Related]
5. Immunosubversive role of PGE2 in tumor bearing mice.
Ippoliti F; Sezzi ML; Bellelli L; Naso G; Pontieri GM
Boll Ist Sieroter Milan; 1985; 64(1):25-34. PubMed ID: 3859302
[TBL] [Abstract][Full Text] [Related]
6. Amplification by macrophages of prostaglandin-mediated immunosuppression in mice bearing syngeneic tumors.
Plescia OJ; Pontieri GM; Brown J; Racis S; Ippoliti F; Bellelli L; Sezzi ML; Lipari M
Prostaglandins Leukot Med; 1984 Nov; 16(2):205-23. PubMed ID: 6597451
[TBL] [Abstract][Full Text] [Related]
7. Suppression of polyclonal, tumor cell and alloantigen-induced proliferation: identification of cyclooxygenase pathway dependent and independent mechanisms.
Hogan KT; Hollingsworth MA; Seymour RE; Quinn MK; Evans DL
Immunopharmacology; 1984 Feb; 7(1):49-57. PubMed ID: 6232242
[TBL] [Abstract][Full Text] [Related]
8. Accelerated growth of syngeneic tumors in mice treated with methylcholanthrene.
Lill PH; Jessup JM; Kripke ML
Int J Cancer; 1978 Apr; 21(4):511-5. PubMed ID: 669850
[TBL] [Abstract][Full Text] [Related]
9. Natural history of mouse syngeneic lymphoma. Morphologic and immunologic aspects.
Jurin M; Drewinko B
Am J Pathol; 1974 Nov; 77(2):213-36. PubMed ID: 4614670
[TBL] [Abstract][Full Text] [Related]
10. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
Fortner GW; Kripke ML
J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
[TBL] [Abstract][Full Text] [Related]
11. Nonspecific resistance to tumor allograft.
Rejthar A; Wotke J; Rejtharová A; Jasková J
Neoplasma; 1975; 22(3):273-8. PubMed ID: 1099469
[TBL] [Abstract][Full Text] [Related]
12. Thymus-derived lymphocyte-dependent rejection of syngeneic papovavirus (SV40) and methylcholanthrene tumors in inbred hamsters.
Blasecki JW
J Immunol; 1977 Nov; 119(5):1621-6. PubMed ID: 199667
[TBL] [Abstract][Full Text] [Related]
13. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors.
Manson LA
Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206
[No Abstract] [Full Text] [Related]
14. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
15. Effect of prostaglandin E in multiple experimental models. VIII. Effect on host response to metastatic tumor.
Waymack JP; Flescher E; Venkatraman J; Fernandes G; Guzman RF; Yurt RW; Mason AD; Pruitt BA
J Surg Oncol; 1991 Dec; 48(4):239-45. PubMed ID: 1745048
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin.
Balza E; Mortara L; Sassi F; Monteghirfo S; Carnemolla B; Castellani P; Neri D; Accolla RS; Zardi L; Borsi L
Clin Cancer Res; 2006 Apr; 12(8):2575-82. PubMed ID: 16638868
[TBL] [Abstract][Full Text] [Related]
17. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
Nagarkatti M; Kaplan AM
J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
[TBL] [Abstract][Full Text] [Related]
18. Allo-skin graft rejection, tumor rejection and natural killer activity in mice lacking p56lck.
Wen T; Zhang L; Kung SK; Molina TJ; Miller RG; Mak TW
Eur J Immunol; 1995 Nov; 25(11):3155-9. PubMed ID: 7489757
[TBL] [Abstract][Full Text] [Related]
19. [Recent data on the immunology of tumors. Mechanisms of escape of immunological control. Role of suppressor cells].
Lespinats G; Poupon MF
Bull Cancer; 1976; 63(2):269-78. PubMed ID: 1086690
[TBL] [Abstract][Full Text] [Related]
20. A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor.
Yuhas JM; Pazmino NH; Proctor JO; Toya RE
Cancer Res; 1974 Apr; 34(4):722-8. PubMed ID: 4360837
[No Abstract] [Full Text] [Related]
[Next] [New Search]
